Mode
Text Size
Log in / Sign up

Early hemodynamic phenotyping may improve risk stratification and prevent pulmonary vascular disease in preterm infantsEarly signs of lung disease in preterm infants identified early

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider early echocardiography and NT-proBNP to identify subclinical pulmonary vascular disease in preterm infants with BPD.

This narrative review synthesizes evidence from experimental, translational, and clinical studies regarding pulmonary vascular growth, ventricular function, and risk stratification in preterm infants with bronchopulmonary dysplasia (BPD). The authors highlight that abnormal pulmonary vascular growth begins early during the transitional circulatory period and is influenced by factors such as hyperoxia, mechanical ventilation, inflammation, placental dysfunction, and altered pulmonary blood flow.

The review emphasizes that prolonged exposure to hemodynamically significant left-to-right shunts can contribute to pulmonary overcirculation and vascular remodeling. Furthermore, elevated pulmonary vascular resistance leads to right ventricular pressure overload, while left ventricular diastolic dysfunction contributes to pulmonary edema. The authors suggest that early hemodynamic assessment using targeted neonatal echocardiography and biomarkers like NT-proBNP allows for the detection of subclinical pulmonary vascular disease (PVD) and ventricular dysfunction during the first days of life.

A limitation noted is that the review synthesizes a broad range of study types, including translational and experimental data. The authors suggest that early hemodynamic phenotyping may improve risk stratification and support precision-guided interventions to prevent BPD-associated pulmonary hypertension and long-term cardiopulmonary sequelae in extremely preterm infants.

How this fits prior evidence

This narrative review addresses gaps in the management of bronchopulmonary dysplasia (BPD) by focusing on early detection of subclinical pulmonary vascular disease. It builds upon previous coverage regarding nursing interventions for BPD and the use of LSTM analysis to detect BPD, but focuses specifically on hemodynamic phenotyping as a tool for risk stratification.

When babies are born very early, they often develop a condition called bronchopulmonary dysplasia (BPD). This lung disease can lead to serious problems with blood flow and pressure in the lungs. New evidence shows that these issues start almost immediately after birth, triggered by factors like oxygen levels and mechanical ventilation.

By using specialized heart scans (echocardiography) and specific markers like NT-proBNP, doctors can find signs of lung damage during the first few days of life. This early detection helps identify babies who might develop pulmonary hypertension, which is high blood pressure in the lungs that strains the heart.

Because these issues start so early, finding them quickly allows for better risk planning. While this review combines several types of studies to show how early screening works, it highlights a path toward more personalized care for tiny patients facing complex lung and heart challenges.

What this means for you:
Early heart scans and biomarkers can help identify hidden lung damage in premature babies with BPD.

Common questions

What is bronchopulmonary dysplasia?

Bronchopulmonary dysplasia (BPD) is a lung disease that can affect babies born very early. It can lead to problems with blood flow and high pressure in the lungs, which may eventually strain the heart.

How are these issues detected so early?

Doctors use targeted neonatal echocardiography (heart scans) and biomarkers like NT-proBNP. These tools help find subclinical pulmonary vascular disease and heart function issues during the first days of life.

What causes these lung problems in premature babies?

Several factors can cause abnormal growth in the lungs' blood vessels, including high oxygen levels (hyperoxia), mechanical ventilation, inflammation, and changes in how blood flows through the lungs.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
ObjectivesBronchopulmonary dysplasia (BPD) remains one of the most important complications of extreme prematurity and a leading cause of long-term respiratory, cardiovascular, and neurodevelopmental morbidity. Increasing evidence suggests that BPD should be viewed not only as a parenchymal lung disorder but as a complex cardiopulmonary syndrome involving disrupted vascular development, abnormal transitional circulation, and ventricular dysfunction. This review aimed to summarize current evidence on the hemodynamic mechanisms underlying BPD, emphasizing pulmonary vascular disease (PVD), bronchopulmonary dysplasia-associated pulmonary hypertension (BPD-PH), phenotype-based classification, and implications for precision management.MethodsA narrative review of experimental, translational, and clinical studies was performed, focusing on pulmonary vascular development, transitional hemodynamics, patent ductus arteriosus, ventricular function, targeted neonatal echocardiography, and biomarker-based risk stratification in preterm infants. Evidence regarding phenotypic classification and individualized therapeutic strategies was also examined.ResultsEmerging evidence demonstrates that abnormal pulmonary vascular growth begins early, often during the transitional circulatory period, and is aggravated by hyperoxia, mechanical ventilation, inflammation, placental dysfunction, and altered pulmonary blood flow. Prolonged exposure to hemodynamically significant left-to-right shunts, particularly patent ductus arteriosus, may contribute to pulmonary overcirculation, edema, and vascular remodeling. Elevated pulmonary vascular resistance leads to right ventricular pressure overload, while left ventricular diastolic dysfunction and pulmonary venous congestion further worsen pulmonary edema and gas exchange. Early hemodynamic assessment using targeted neonatal echocardiography and biomarkers such as NT-proBNP enables detection of subclinical PVD and ventricular dysfunction during the first days of life. Phenotype-based classification reveals overlapping parenchymal, interstitial, congestive, vascular, and airway components, supporting individualized cardiopulmonary management.ConclusionsBPD is increasingly recognized as a heterogeneous cardiopulmonary syndrome in which disturbed hemodynamics and impaired cardiopulmonary coupling play central roles in disease progression and prognosis. Early hemodynamic phenotyping may improve risk stratification, support precision-guided interventions, and offer new opportunities to prevent PVD, BPD-PH, and long-term cardiopulmonary sequelae in extremely preterm infants.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.